Table 4. Test of difference in hematologic and clinical chemistry parameters between gender and age-groups from the 16–34 years old cohort in Kisumu Kenya (2007–2010).
Age 16–17 years | Age 18–34 years | |||||||
---|---|---|---|---|---|---|---|---|
Parameter | Gender | n | median | p-value (gender) | n | median | p-value (gender) | P-value (age) |
Hemoglobin (g/dL) | Female | 132 | 12.7 (7.5–14.8) | <0.0001 | 322 | 12.8 (9.0–14.9) | <0.0001 | 0.3143 |
Male | 110 | 14.2 (11.1–16.7) | 389 | 15.1 (12.6–17.2) | <0.0001 | |||
Hematocrit (%) | Female | 132 | 38.0 (24.2–43.7) | <0.0001 | 322 | 38.6 (28.6–44.2) | <0.0001 | 0.2242 |
Male | 110 | 42.6 (33.7–49.7) | 389 | 45.4 (38.1–51.6) | <0.0001 | |||
WBC (x1000) | Female | 132 | 6.0 (3.6–9.5) | 0.0025 | 322 | 5.9 (3.7–9.1) | 0.0002 | 0.4387 |
Male | 110 | 5.2 (3.6–9.1) | 389 | 5.6 (3.3–9.6) | 0.5766 | |||
RBC (x10 12 /L) | Female | 132 | 4.9 (3.7–6.0) | <0.0001 | 322 | 4.8 (4.0–5.8) | <0.0001 | 0.4424 |
Male | 110 | 5.2 (4.3–6.4) | 389 | 5.4 (4.6–6.6) | <0.0001 | |||
Lymphocytes (x10 9 /L) | Female | 132 | 2.5 (1.2–3.9) | 0.0112 | 322 | 2.3 (1.4–3.8) | <0.0001 | 0.0789 |
Male | 110 | 2.2 (1.4–3.4) | 389 | 2.1 (1.2–3.4) | 0.0261 | |||
Neutrophiles (x10 9 /L) | Female | 132 | 2.7 (1.3–5.8) | 0.0112 | 322 | 2.7 (1.3–5.0) | 0.0538 | 0.4565 |
Male | 110 | 2.2 (0.9–6.7) | 389 | 2.6 (1.3–5.2) | 0.0169 | |||
PLT(x10 9 /L) | Female | 132 | 264 (126–448) | <0.0001 | 322 | 270 (147–454) | <0.0001 | 0.3589 |
Male | 110 | 215 (112–474) | 389 | 227 (126–356) | 0.1218 | |||
ALT (μ/L) | Female | 132 | 14.1 (5.7–32.5) | 0.0030 | 322 | 13.5 (7.2–34.1) | <0.0001 | 0.2750 |
Male | 110 | 16.4 (7.8–33.9) | 388 | 17.4 (8.4–54.7) | 0.0417 | |||
BUN (mmol/L) | Female | 132 | 2.4 (1.2–4.2) | 0.0241 | 322 | 2.4 (1.2–4.1) | <0.0001 | 0.7883 |
Male | 110 | 2.7 (1.2–4.5) | 388 | 2.8 (1.5–5.0) | 0.0604 | |||
Creatinine (μmol/L) | Female | 132 | 51 (40–69) | <0.0001 | 322 | 78 (57–100) | <0.0001 | <0.0001 |
Male | 110 | 65 (39–89) | 388 | 93 (69–123) | <0.0001 |